Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure

Cardiovascular Research

Volumn 57, Issue 3, 2003, Pages 749-756

  Frantz, Stefan ^a   Fraccarollo, Daniela ^a   Wagner, Helga ^a   Behr, Thomas M ^a   Jung, Philip ^a   Angermann, Christiane E ^a   Ertl, Georg ^a   Bauersachs, Johann ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Cytokines; Immunology; Infarction; Remodeling

Indexed keywords

CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PLACEBO; PROTEIN; TOLL LIKE RECEPTOR; TRANDOLAPRIL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL TEST; HEART DILATATION; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNITY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PROCESSING; RAT; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BIPHENYL COMPOUNDS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART FAILURE, CONGESTIVE; HUMANS; INDOLES; INTERLEUKIN-1; MALE; MYOCARDIAL INFARCTION; NF-KAPPA B; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; TETRAZOLES; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037370148     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00723-X     Document Type: Article

References (35)

1. Gilmore T. The Rel/NF-kB signal transduction pathway: introduction. Oncogene. 18:1999;6842-6844.
2. Norman D.A., Yacoub M.H., Barton P.J. Nuclear factor NF-kappa B in myocardium: developmental expression of subunits and activation by interleukin-1 beta in cardiac myocytes in vitro. Cardiovasc Res. 39:1998;434-441.
3. Zandi E., Karin M. Bridging the gap: composition, regulation, and physiological function of the IkB kinase complex. Mol Cell Biol. 19:1999;4547-4551.
4. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 16:1998;225-260.
5. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 18:1999;6853-6866.
6. Frantz S., Kobzik L., Kim Y.D., et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest. 104:1999;271-280.
7. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 270:1995;16483-16486.
8. Frantz S., Kelly R.A. Innate immunity and Toll Like Receptor 4 in the Failing Heart. Navarro-Lòpez F. XXI Congress of the European Society of Cardiology. 1999;505-508 Monduzzi Editore, Bologna, Italy.
9. Fraccarollo D., Hu K., Galuppo P., Gaudron P., Ertl G. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling. Circulation. 96:1997;3963-3973.
10. Bauersachs J., Galuppo P., Fraccarollo D., Christ M., Ertl G. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction. Circulation. 104:2001;982-985.
11. Bourcier T. Methods in molecular medicine: vascular disease. 1999;159-167 Humana Press, Totowa, NJ, USA.
12. Frantz S., Kelly R.A., Bourcier T. Role of TLR-2 in the activation of nuclear factor-kappa B by oxidative stress in cardiac myocytes. J Biol Chem. 276:2001;5197-5203.
13. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:1986;705-716.
14. Baeuerle P.A., Baltimore D. NF-kappa B: 10 years after. Cell. 87:1996;13-20.
15. Valen G., Yan Z.Q., Hansson G.K. Nuclear factor kappa-B and the heart. J Am Coll Cardiol. 38:2001;307-314.
16. Shimizu N., Yoshiyama M., Omura T., et al. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. Cardiovasc Res. 38:1998;116-124.
17. Chandrasekar B., Freeman G.L. Induction of nuclear factor kappaB and activation protein 1 in postischemic myocardium. FEBS Lett. 401:1997;30-34.
18. Morgan E.N., Boyle E.M. Jr., Yun W., et al. An essential role for NF-kappaB in the cardioadaptive response to ischemia. Ann Thorac Surg. 68:1999;377-382.
19. Morishita R., Sugimoto T., Aoki M., et al. In vivo transfection of cis element 'decoy' against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med. 3:1997;894-899.
20. Xuan Y.T., Tang X.L., Banerjee S., et al. Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res. 84:1999;1095-1099.
21. Wong S.C., Fukuchi M., Melnyk P., Rodger I., Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation. 98:1998;100-103.
22. Grabellus F., Levkau B., Sokoll A., et al. Reversible activation of nuclear factor-kB in human end-stage heart failure after left ventricular mechanical support. Cardiovasc Res. 53:2002;124-130.
23. Irwin M.W., Mak S., Mann D.L., et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation. 99:1999;1492-1498.
24. Lapointe N., Blais C., Adam A., et al. Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat. J Am Coll Cardiol. 39:2002;1692-1698.
25. Kalra D., Sivasubramanian N., Mann D.L. Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway. Circulation. 105:2002;2198-2205.
26. Kalra D.K., Zhu X., Ramchandani M.K., et al. Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans. Circulation. 105:2002;1537-1540.
27. Ono K., Matsumori A., Shioi T., Furukawa Y., Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation. 98:1998;149-156.
28. Baumgarten G., Knuefermann P., Kalra D., et al. Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart. Circulation. 105:2002;2192-2197.
29. Wei G.C., Sirois M.G., Qu R., Liu P., Rouleau J.L. Subacute and chronic effects of quinapril on cardiac cytokine expression, remodeling, and function after myocardial infarction in the rat. J Cardiovasc Pharmacol. 39:2002;842-850.
30. Heymes C., Vanderheyden M., Bronzwaer J.G., Shah A.M., Paulus W.J. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation. 99:1999;3009-3016.
31. Commitee OS, Group OS. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Lancet. 360:2002;752-760.
32. Pitt B., Poole-Wilson P.A., Segal R., et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II. Lancet. 355:2000;1582-1587.
33. Hu K., Gaudron P., Anders H.J., et al. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. Cardiovasc Res. 39:1998;401-412.
34. Ruiz-Ortega M., Lorenzo O., Ruperez M., Blanco J., Egido J. Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol. 158:2001;1743-1756.
35. Yoshiyama M., Omura T., Takeuchi K., et al. Angiotensin blockade inhibits increased JNKs, AP-1 and NF-kappa B DNA-binding activities in myocardial infarcted rats. J Mol Cell Cardiol. 33:2001;799-810.